Digoxin and Reduction of Heart Failure Hospitalization in Chronic Systolic and Diastolic Heart Failure

American Journal of Cardiology

Volumn 102, Issue 12, 2008, Pages 1681-1686

  Meyer, Philippe ^a   White, Michel ^a   Mujib, Marjan ^b   Nozza, Anna ^a   Love, Thomas E ^d   Aban, Inmaculada ^b   Young, James B ^e   Wehrmacher, William H ^f   Ahmed, Ali ^b,c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; PLACEBO;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; DIASTOLIC HEART FAILURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HAZARD RATIO; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SYSTOLIC HEART FAILURE; TREATMENT OUTCOME;

AGED; CARDIOTONIC AGENTS; DIGOXIN; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS;

EID: 57649106630     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.05.068     Document Type: Article

References (22)

1. Hunt S.A. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 suppl (2005) e1-e82
2. Ahmed A., Perry G.J., Fleg J.L., Love T.E., Goff Jr. D.C., and Kitzman D.W. Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis. Am Heart J 152 (2006) 956-966
3. Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A., Gong Y., and Liu P.P. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 (2006) 260-269
4. Ahmed A., Allman R.M., Fonarow G.C., Love T.E., Zannad F., Dell'italia L.J., White M., and Gheorghiade M. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. J Card Fail 14 (2008) 211-218
5. The Digitalis Investigation Group Investigators. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 (1997) 525-533
6. Ahmed A., Rich M.W., Fleg J.L., Zile M.R., Young J.B., Kitzman D.W., Love T.E., Aronow W.S., Adams Jr. K.F., and Gheorghiade M. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 114 (2006) 397-403
7. Ahmed A., Young J.B., and Gheorghiade M. The underuse of digoxin in heart failure, and approaches to appropriate use. CMAJ 176 (2007) 641-643
8. Gheorghiade M., Zannad F., Sopko G., Klein L., Pina I.L., Konstam M.A., Massie B.M., Roland E., Targum S., Collins S.P., Filippatos G., and Tavazzi L. Acute heart failure syndromes: current state and framework for future research. Circulation 112 (2005) 3958-3968
9. Yusuf S., Pfeffer M.A., Swedberg K., Granger C.B., Held P., McMurray J.J., Michelson E.L., Olofsson B., and Ostergren J. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362 (2003) 777-781
10. The Digitalis Investigation Group Investigators, and Digitalis Investigation Group. Protocol: Trial to Evaluate the Effect of Digitalis on Mortality in Heart Failure (1991), National Heart, Lung, and Blood Institute, Bethesda, MD
11. Ahmed A., Rich M.W., Love T.E., Lloyd-Jones D.M., Aban I.B., Colucci W.S., Adams K.F., and Gheorghiade M. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 27 (2006) 178-186
12. Collins J.F., Howell C.L., and Horney R.A. Determination of vital status at the end of the DIG trial. Control Clin Trials 24 (2003) 726-730
13. Ahmed A., Husain A., Love T.E., Gambassi G., Dell'Italia L.J., Francis G.S., Gheorghiade M., Allman R.M., Meleth S., and Bourge R.C. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27 (2006) 1431-1439
14. Levesque R. Macros. SPSS Programming and Data Management. 2nd Ed. (2005), SPSS, Chicago. http://www.spsstools.net/spss_programming.htm A Guide for SPSS and SAS Users
15. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
16. Normand S.T., Landrum M.B., Guadagnoli E., Ayanian J.Z., Ryan T.J., Cleary P.D., and McNeil B.J. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 54 (2001) 387-398
17. Rothwell P.M. Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 365 (2005) 176-186
18. Rathore S.S., Curtis J.P., Wang Y., Bristow M.R., and Krumholz H.M. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289 (2003) 871-878
19. Cleland J.G.F., Tendera M., Adamus J., Freemantle N., Polonski L., Taylor J., and PEPCHFI. The Perindopril in Elderly People with Chronic Heart Failure (PEP-CHF) study. Eur Heart J 27 (2006) 2338-2345
20. Carson P., Massie B.M., McKelvie R., McMurray J., Komajda M., Zile M., Ptaszynska A., and Frangin G. The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design. J Card Fail 11 (2005) 576-585
21. TOPCAT Study Investigators. Treatment of preserved cardiac function heart failure with an aldosterone antagonist. http://www.topcatstudy.com/ Accessed March 17, 2008.
22. Yancy C.W., Lopatin M., Stevenson L.W., De Marco T., and Fonarow G.C. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 47 (2006) 76-84